What recent news is there about ACS BrightEdge?

Recent news includes the ACS BrightEdge Annual Report, Third Rock Ventures partnership, BrightEdge Entrepreneurs Program, Golden Ticket Pitch Competition, and the impact of $43 million deployed to advance innovation and healthcare access. Source: ACS BrightEdge

Overview

ACS BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society.

Investment Focus

Focusing on early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies.

Investment Stages

Primarily early-stage investments.

Industries

HealthTech, Biotech, Oncology, Pharmacology, Philanthropy, Fundraising.

Technology Focus

Cancer-focused therapeutics, diagnostics, devices, and technologies.

More Questions About ACS BrightEdge

What is ACS BrightEdge?

ACS BrightEdge is the innovation, impact investment, and venture capital arm of the American Cancer Society, focusing on early-stage companies developing cancer-focused therapeutics, diagnostics, devices, and technologies.

Where is ACS BrightEdge located?

ACS BrightEdge is located in Kennesaw, United States.

When was ACS BrightEdge founded?

This information is not publicly available.

What type of investor is ACS BrightEdge?

ACS BrightEdge is a Corporate VC and VC Firm.

Does ACS BrightEdge invest in HealthTech?

Yes, ACS BrightEdge invests in HealthTech.

Does ACS BrightEdge invest in Biotech?

Yes, ACS BrightEdge invests in Biotech.

Verification Confidence: 90% | Source: accepts_cold_outreach | Entity: ACS BrightEdge